快速康复外科理念在膀胱癌患者根治性全膀胱切除术围术期护理中的应用效果

目的 分析快速康复外科(FTS)理念在膀胱癌(BC)患者根治性全膀胱切除术围术期护理中的应用效果。方法 回顾性收集我院147例BC患者,均接受根治性全膀胱切除术治疗,将2017年1月～2018年10月在围术期接受常规护理干预的73例作为对照组,将2020年1月～2021年10月在围术期接受FTS理念干预的74例作为观察组,比较两组围术期情况、不同时间点(术前1d、术后1h、1d)疼痛程度、并发症。结果 观察组术后首次下床活动、术后首次排气以及住院时间均短于对照组(P＜0.05);两组不同时间、组间、交互作用下视觉模拟疼痛评分(VAS评分)比较,差异具有统计学意义(P＜0.05),两组术前1d VAS评分比较,无明显差异(P＞0.05);而与对照组术后1h、1d VAS评分相比,观察组均较低(P＜0.05);观察组、对照组并发症发生率分别为31.08%、41.10%,组间比较,无明显差异(P＞0.05)。结论 FTS理念应用于BC患者,能减轻疼痛程度,缩短术后首次下床活动、术后首次排气时间,促进术后恢复。     

A nationwide post-marketing survey of knowledge,attitude and practice toward human papillomavirus vaccine in general population: Implications for vaccine roll-out in mainland China

BackgroundHuman papillomavirus (HPV) vaccine has been increasingly discussed in mainland China since its first approval in 2016. To date, nearly all studies assessing HPV vaccine perceptions and attitudes were implemented during pre-licensure period. Therefore, the nationwide post-marketing survey was conducted to update knowledge, attitudes and practice on HPV vaccine among general population in mainland China.MethodsParticipants aged 18–45 years living in mainland China were recruited in April 2019 by multi-stage non-randomized sampling. Sociodemographic factors, HPV and HPV vaccine related awareness, knowledge, attitudes, vaccine uptake and potential obstacles were assessed in questionnaires. Bivariate analysis and multivariate regression were used to identify disparity among subgroups with different sociodemographic characteristics.Results4,000 women (32.1 ± 7.81y) and 1,000 men (31.8 ± 7.96y) were included in final analysis. Less than one third of participants had heard of HPV (female: 31%; male: 22%) and HPV vaccine (female: 34%; male: 23%). Knowledge score was also unfavorable on HPV (female: 3 out of 13; male: 1.8 out of 13) and HPV vaccine (female: 3 out of 6; male: 2 out of 5). Only 3% females had been vaccinated three years after HPV licensure in China, although willingness to get vaccinated among those unvaccinated were high (mean willingness score ± SD: female: 3.3 ± 0.97; male: 3.0 ± 0.98). Industry of employment and household income were the major factors related to awareness and knowledge of vaccine, whereas HPV and HPV vaccine awareness were key influential factors for willingness. The main obstacles of vaccination were safety concerns, lack of knowledge, and high price of HPV vaccines.ConclusionsFindings highlight a lack of vaccine awareness, knowledge, and poor uptake in mainland China and underscore the necessity of health education campaigns. The identified priority groups, contents to be delivered and practical obstacles could furthermore provide insight into health education to reduce disparities and accelerate HPV vaccine roll-out in China.     

医疗机构执行新型冠状病毒肺炎疫情防控任务的物资保障

2019年12月,武汉市发生了新型冠状病毒肺炎疫情。作为确诊或疑似患者的收治场所,医疗机构对个人防护用品、消杀类产品及相关药品的需求量剧增,各医疗机构的物资保障体系均经受了严峻的考验。该研究结合医院实践,针对疫情下的应急物资管理提出几点建议:加强组织领导,健全医疗机构的应急物资保障体系;提升预判能力,尽早启动紧急采购预案,增加物资的库房储备;加强物资管控,将有限的应急物资优先安排于重点岗位,避免资源浪费。该研究还讨论了本次突发的传染病疫情为医疗机构在物资保障方面带来的启示,以期能够为医疗机构制订传染病疫情应急物资保障策略提供参考。     

TS mRNA 水平对食管癌化疗的预测价值

 目的 探讨化疗前食管癌组织中胸苷酸合成酶(thymidylate synthase,TS)转录水平及其对顺铂/5-氟脲嘧啶(DDP/5-Fu)疗效的预测价值. 方法 20例食管癌患者均接受2个周期DDP/5-Fu化疗.DDP 15～20 mg/m2/d,iv d1-5;5-Fu 375～500 mg/m2/d,ivgtt 8 h,d1-5,休息4周后,进行第二个周期化疗.以β-肌动蛋白(β-actin)作内参照,应用半定量RT-PCR技术检测化疗前食管癌癌组织中TS mRNA水平,以TS/Β-actin比值表示.实验数据经SPSS 10.0统计软件处理,化疗有效和无效组间TS mRNA水平间差异分析采用Wilcoxon秩和检验;双侧检验,α取0.05作为显著性检验的标准. 结果 20例食管癌患者中,11例化疗有效者的TS/β-actin mRNA水平中位值为3.90×10-1,而9例化疗无效者的TS/β-actin mRNA水平中位值为9.10×10-1,两组差异具有统计学意义(P<0.05). 结论 化疗前食管癌组织中TS mRNA水平对应用DDP/5-Fu治疗食管癌的疗效具有一定预测价值.     

视网膜母细胞瘤的遗传学特征及临床筛查与治疗

视网膜母细胞瘤(RB)是儿童最常见的眼内恶性肿瘤,多发于婴幼儿,可损害患儿视力、眼球,甚至危及生命。其发生和发展与基因组和表观基因组有很大关系,遗传性RB占所有病例的45%。RB的治疗和预后取决于疾病的初始阶段,当疾病被早期诊断和治疗时,存活率超过95%,当RB在晚期发生眼外播散时,存活率低于50%。因此RB的治疗重点是通过早期肿瘤的监测和预防挽救患儿生命,其次要目标是保存眼球,并最大水平地保留视力。对RB遗传学的研究有助于通过基因筛查、监测查找特异性靶点,对提高患儿的生存率、研究RB靶向治疗十分必要。     

转移性肾癌免疫治疗研究进展

转移性肾癌对传统放、化疗均不敏感,目前尚缺乏有效的治疗手段.IL-2和IFN-α是目前研究较多的细胞因子制剂,但单独应用于转移性肾癌患者的治疗时效率低.近年来,随着分子免疫机制的研究进展,疫苗、过继免疫治疗的研究发展迅速,特别是树突状细胞疫苗(DC vaccine)和自体细胞因子诱导的杀伤细胞(CIK)的研究取得了很大的进展.     

Safety and diagnostic accuracy of percutaneous CT-guided transthoracic biopsy of small lung nodules (≤20 mm) adjacent to the pericardium or great vessels

PURPOSEWe aimed to evaluate the safety and diagnostic accuracy of computed tomography (CT)-guided transthoracic biopsy of small lung nodules (≤20 mm) adjacent to the pericardium or great vessels.METHODSThis retrospective study examined the safety and diagnostic accuracy of percutaneous CT-guided biopsy for small lung nodules (≤20 mm) located within 10 mm of the pericardium or great vessels. Technical aspects and factors influencing complications were assessed, and diagnostic accuracy was calculated.RESULTSA total of 168 biopsies were performed in 168 patients. The complications were mainly pneumothorax (34.5%; 58 of 168 patients), chest tube insertion (5.3%; 9 of 168 patients), and pulmonary hemorrhage (61.3%; 103 of 168 procedures), with no patient mortality. One patient (0.6%) was admitted because of hemorrhage complications. Significant independent risk factors for pneumothorax were nodules resided in upper or middle lobes and lateral patient position, and for hemorrhage, longer distance from structures and longer needle trajectory through the lung parenchyma. Overall, the sensitivity, accuracy, and specificity were 91.0%, 92.2%, and 100%, respectively.CONCLUSIONPercutaneous CT-guided transthoracic biopsy was highly accurate in small lung nodules (≤20 mm) adjacent to the pericardium or great vessels. Complications are common, but most were minor and self-limited.

In recent years, with wide availability of computed tomography (CT) and the development of low-dose CT screening techniques, more small lung nodules (≤20 mm) have been detected (1–3). Lee et al. (4) reported that small lung nodules were detected at a rate of 44.5%, and that 39.7% of lung cancers were found in small nodules. Accurate histopathological diagnosis is of great importance in management of these nodules, but biopsy via fluoroscopy or ultrasound guidance is technically more difficult, and CT guidance is usually required (5).Percutaneous CT-guided transthoracic lung biopsy is a reasonably safe and accurate approach to the histological diagnosis of primary and secondary lung nodules (4, 6, 7). However, nodule size is the major determinant of diagnostic accuracy, which reached 96.9% for larger nodules (7), but ranged from 52% to 78.8% for small nodules (8, 9).Biopsy of small lung nodules close to proximity to the pericardium or great vessels is particularly challenging, and precise needle placement is essential to avoid complications resulting from non-target tissue injury near vital mediastinal or vascular structures. Hsu et al. (10) suggested that CT-guided lung biopsy should be avoided if the adjacent nodule is within 10 mm of the pericardium.The authors know of no related studies of biopsy of small lung nodules close to the pericardium or great vessels. This study, therefore, was conducted to examine the safety and diagnostic accuracy of CT-guided transthoracic biopsy of small lung nodules (≤20 mm) within 10 mm of the pericardium or great vessels.     

中国胰腺癌发病趋势分析和预测

目的利用中国肿瘤登记地区1998-2007年胰腺癌发病登记数据分析胰腺癌发病趋势，并预测2008--2015年中国胰腺癌的发病情况。方法计算各年份胰腺癌的粗发病率，直接法计算中国人口标准化率，采用JoinPoint软件对中国肿瘤登记地区1998-2007年胰腺癌发病数据进行趋势分析，计算年度平均变化率。应用贝叶斯年龄一时期一队列模型对数据进行拟合，估计年龄、时期、队列参数效应并预测2008-2015年全国胰腺癌发病情况。结果1998-2007年城市男性粗发病率每年以1．86%的比例上升，中国人口标准化率上升趋势不明显；女性粗发病率每年上升2．1%，中国人口标准化率上升趋势不明显。农村男性粗发病率每年上升7．54%，中国人口标准化率每年上升4．82%；女性分别上升7．83%和5．48%。预测模型显示年龄效应、时期效应和队列效应均在胰腺癌发病中起重要作用。估计2015年新发胰腺癌103 428例，其中男性60 500例，女性42 928例，较2008年增加15 277例。结论中国胰腺癌发病率呈上升趋势，其中农村地区上升明显，城市地区上升速度略缓，到2015年总体上升趋势有所减缓，但短期内胰腺癌仍然是主要癌症。